← Back to Clinical Trials
Recruiting NCT06453525

NCT06453525 PrediSuisse: Automatized Assessment of Difficult Airway

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06453525
Status Recruiting
Phase
Sponsor Centre Hospitalier Universitaire Vaudois
Condition Anesthesia
Study Type OBSERVATIONAL
Enrollment 1,800 participants
Start Date 2025-01-01
Primary Completion 2026-11-15

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 100 Years
Study Type OBSERVATIONAL
Interventions
intubation

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 1,800 participants in total. It began in 2025-01-01 with a primary completion date of 2026-11-15.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

In the "PrediSuisse" research project, the investigators aim to create a reliable, reproducible, ultra-portable and radiation-free automatized software, able to identify automatically collected features, facial characteristics, and range of movements, to predict intubation difficulty. The software will generate a difficulty intubation score tailored to three commercially available videolaryngoscopes with different type of blades, corresponding to the predicted endotracheal intubation difficulty while providing the anaesthesiologist a reliable and non-subjective tool to assess individual patient's risks with regards to airway management.

Eligibility Criteria

Inclusion Criteria: * Adult patients (≥ 18 years old) presenting at the pre-anesthesia consult for an elective general anesthesia necessitating a tracheal intubation * Signed informed consent. Exclusion Criteria: * Patients not speaking French (in Geneva and Lausanne) or Italian (in Lugano). * Patients previously operated on the airway with anatomical modifications (ENT Flaps, tracheotomies). * Patients unable to follow procedures or to give consent will also be excluded.

Contact & Investigator

Central Contact

Patrick Schoettker, PhD

✉ patrick.schoettker@chuv.ch

📞 +41213142007

Principal Investigator

Patrick Schoettker, PhD

PRINCIPAL INVESTIGATOR

Centre Hospitalier Universitaire Vaudois

Frequently Asked Questions

Who can join the NCT06453525 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 100 Years, studying Anesthesia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06453525 currently recruiting?

Yes, NCT06453525 is actively recruiting participants. Contact the research team at patrick.schoettker@chuv.ch for enrollment information.

Where is the NCT06453525 trial being conducted?

This trial is being conducted at Lausanne, Switzerland.

Who is sponsoring the NCT06453525 clinical trial?

NCT06453525 is sponsored by Centre Hospitalier Universitaire Vaudois. The principal investigator is Patrick Schoettker, PhD at Centre Hospitalier Universitaire Vaudois. The trial plans to enroll 1,800 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology